Statement Of Financial Position [Abstract]

ABIVAX - Filing #5984181

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Goodwill
18 419 EUR
18 419 EUR
18 419 EUR
Intangible assets other than goodwill
6 606 EUR
6 604 EUR
6 607 EUR
Cash and cash equivalents
144 221 EUR
251 942 EUR
26 950 EUR
60 701 EUR
Assets
205 228 EUR
327 062 EUR
75 544 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
633,000 EUR
629,000 EUR
223,000 EUR
Share premium
478 905 EUR
478 218 EUR
150 476 EUR
Equity attributable to owners of parent
196 010 EUR
7 189 EUR
Equity
262 637 EUR
478 905 EUR
633,000 EUR
75,000 EUR
40 584 EUR
40 584 EUR
176 242 EUR
196 010 EUR
135 209 EUR
147 740 EUR
478 218 EUR
629,000 EUR
112,000 EUR
196 010 EUR
7 189 EUR
82 770 EUR
60 740 EUR
150 476 EUR
223,000 EUR
EUR
7 189 EUR
42 452 EUR
25 934 EUR
39 361 EUR
107 578 EUR
EUR
168,000 EUR
Equity and liabilities
205 228 EUR
327 062 EUR
75 544 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.